{"id":"https://openalex.org/W3088091778","doi":"https://doi.org/10.1038/s41598-020-72967-8","title":"Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials","display_name":"Assessing the need for pioglitazone in the treatment of patients with type 2 diabetes: a meta-analysis of its risks and benefits from prospective trials","publication_year":2020,"publication_date":"2020-09-25","ids":{"openalex":"https://openalex.org/W3088091778","doi":"https://doi.org/10.1038/s41598-020-72967-8","mag":"3088091778","pmid":"https://pubmed.ncbi.nlm.nih.gov/32978507","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7519682"},"language":"en","primary_location":{"id":"doi:10.1038/s41598-020-72967-8","doi":"https://doi.org/10.1038/s41598-020-72967-8","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-020-72967-8","pdf_url":"https://www.nature.com/articles/s41598-020-72967-8.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.nature.com/articles/s41598-020-72967-8.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5020877386","display_name":"Binayak Sinha","orcid":"https://orcid.org/0000-0002-6385-0999","observed_orcids":["https://orcid.org/0000-0002-6385-0999"]},"institutions":[{"id":"https://openalex.org/I46827455","display_name":"AMRI Hospitals","ror":"https://ror.org/006p8df44","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I46827455"]}],"countries":["IN"],"is_corresponding":false,"raw_author_name":"Binayak Sinha","raw_affiliation_strings":["AMRI Hospitals KB 24, KB Block, Sector III, Bidhannagar, Kolkata, 700098, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AMRI Hospitals KB 24, KB Block, Sector III, Bidhannagar, Kolkata, 700098, India","institution_ids":["https://openalex.org/I46827455"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5055948821","display_name":"Samit Ghosal","orcid":"https://orcid.org/0000-0002-4141-5187","observed_orcids":["https://orcid.org/0000-0002-4141-5187"]},"institutions":[{"id":"https://openalex.org/I4210158225","display_name":"Nightingale Hospital","ror":"https://ror.org/05r0sm904","country_code":"IN","type":"healthcare","lineage":["https://openalex.org/I4210158225"]}],"countries":["IN"],"is_corresponding":true,"raw_author_name":"Samit Ghosal","raw_affiliation_strings":["Nightingale Hospital, 11 Shakespeare Sarani, Kolkata, 700071, India. ramdasghosal@gmail.com","Nightingale Hospital, 11 Shakespeare Sarani, Kolkata, 700071, India"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nightingale Hospital, 11 Shakespeare Sarani, Kolkata, 700071, India. ramdasghosal@gmail.com","institution_ids":["https://openalex.org/I4210158225"]},{"raw_affiliation_string":"Nightingale Hospital, 11 Shakespeare Sarani, Kolkata, 700071, India","institution_ids":["https://openalex.org/I4210158225"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5055948821"],"corresponding_institution_ids":["https://openalex.org/I4210158225"],"apc_list":{"value":1870,"currency":"USD","value_usd":1870},"apc_paid":{"value":1870,"currency":"USD","value_usd":1870},"fwci":0.6375,"has_fulltext":true,"cited_by_count":51,"citation_normalized_percentile":{"value":0.5892326,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"10","issue":"1","first_page":"15781","last_page":"15781"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9961000084877014,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0010000000474974513,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10198","display_name":"Heart Failure Treatment and Management","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9959999918937683},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9919999837875366},{"id":"https://openalex.org/keywords/major-adverse-cardiovascular-events","display_name":"major adverse cardiovascular events","score":0.8069999814033508},{"id":"https://openalex.org/keywords/heart-failure","display_name":"heart failure","score":0.9179999828338623},{"id":"https://openalex.org/keywords/heart-failure-hospitalization","display_name":"heart failure hospitalization","score":0.7480000257492065},{"id":"https://openalex.org/keywords/fracture","display_name":"fracture","score":0.621999979019165},{"id":"https://openalex.org/keywords/anemia","display_name":"anemia","score":0.9819999933242798},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.7570000290870667},{"id":"https://openalex.org/keywords/macular-edema","display_name":"macular edema","score":0.9819999933242798},{"id":"https://openalex.org/keywords/risk-benefit-assessment","display_name":"risk-benefit assessment","score":0.8479999899864197},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.8059999942779541},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.4350000023841858},{"id":"https://openalex.org/keywords/stroke","display_name":"stroke","score":0.6159999966621399},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5690000057220459},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.3659999966621399},{"id":"https://openalex.org/keywords/anti-hyperglycemic-agents","display_name":"anti-hyperglycemic agents","score":0.7149999737739563},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.41100001335144043}],"concepts":[{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.9347496628761292},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8614137172698975},{"id":"https://openalex.org/C156957248","wikidata":"https://www.wikidata.org/wiki/Q1862216","display_name":"Odds ratio","level":2,"score":0.7394299507141113},{"id":"https://openalex.org/C95190672","wikidata":"https://www.wikidata.org/wiki/Q815382","display_name":"Meta-analysis","level":2,"score":0.7122845649719238},{"id":"https://openalex.org/C187960798","wikidata":"https://www.wikidata.org/wiki/Q7631152","display_name":"Subgroup analysis","level":3,"score":0.6749961972236633},{"id":"https://openalex.org/C2776478404","wikidata":"https://www.wikidata.org/wiki/Q1105187","display_name":"Cochrane Library","level":3,"score":0.6438822746276855},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.6272551417350769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6041733622550964},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.5675506591796875},{"id":"https://openalex.org/C2780645631","wikidata":"https://www.wikidata.org/wiki/Q671554","display_name":"Stroke (engine)","level":2,"score":0.5228246450424194},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.49328941106796265},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4641517400741577},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.41308867931365967},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.10271215438842773},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.07031065225601196},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.05691668391227722},{"id":"https://openalex.org/C78519656","wikidata":"https://www.wikidata.org/wiki/Q101333","display_name":"Mechanical engineering","level":1,"score":0.0},{"id":"https://openalex.org/C127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002986","descriptor_name":"Clinical Trials as Topic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018570","descriptor_name":"Risk Assessment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1038/s41598-020-72967-8","doi":"https://doi.org/10.1038/s41598-020-72967-8","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-020-72967-8","pdf_url":"https://www.nature.com/articles/s41598-020-72967-8.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7519682","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/7519682","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Sci Rep","raw_type":"Text"},{"id":"pmid:32978507","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/32978507","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific reports","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/s41598-020-72967-8","doi":"https://doi.org/10.1038/s41598-020-72967-8","is_oa":true,"landing_page_url":"https://doi.org/10.1038/s41598-020-72967-8","pdf_url":"https://www.nature.com/articles/s41598-020-72967-8.pdf","source":{"id":"https://openalex.org/S196734849","display_name":"Scientific Reports","issn_l":"2045-2322","issn":["2045-2322"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319908","host_organization_name":"Nature Portfolio","host_organization_lineage":["https://openalex.org/P4310319908","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Nature Portfolio","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Scientific Reports","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/systematic-review","display_name":"Systematic Review"},{"id":"https://openalex.org/study-designs/meta-analysis","display_name":"Meta-Analysis"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3088091778.pdf","grobid_xml":"https://content.openalex.org/works/W3088091778.grobid-xml"},"referenced_works_count":30,"referenced_works":["https://openalex.org/W1128528964","https://openalex.org/W1523312932","https://openalex.org/W1554040650","https://openalex.org/W1562731587","https://openalex.org/W1949954933","https://openalex.org/W1963852432","https://openalex.org/W1991113982","https://openalex.org/W1997416444","https://openalex.org/W2036169665","https://openalex.org/W2040493457","https://openalex.org/W2056867141","https://openalex.org/W2075646098","https://openalex.org/W2094564105","https://openalex.org/W2121264929","https://openalex.org/W2127125241","https://openalex.org/W2134177734","https://openalex.org/W2142336725","https://openalex.org/W2155043929","https://openalex.org/W2159969745","https://openalex.org/W2163010737","https://openalex.org/W2274836352","https://openalex.org/W2565236356","https://openalex.org/W2568525643","https://openalex.org/W2755083612","https://openalex.org/W2894993577","https://openalex.org/W2895533920","https://openalex.org/W3027389968","https://openalex.org/W4240449862","https://openalex.org/W4252649697","https://openalex.org/W4253996779"],"related_works":["https://openalex.org/W2568525643","https://openalex.org/W1990724339","https://openalex.org/W2075692188","https://openalex.org/W2142271188","https://openalex.org/W1523312932","https://openalex.org/W4200010739","https://openalex.org/W2996104596","https://openalex.org/W1999225509","https://openalex.org/W2013498567","https://openalex.org/W2759795092"],"abstract_inverted_index":{"The":[0,69,116,247],"safety":[1],"and":[2,22,77,100,114,134,151,223,266,295],"usefulness":[3],"of":[4,33,109,118,140,178,204,214,262,275],"pioglitazone":[5,79],"(Pio)":[6],"is":[7],"repeatedly":[8],"called":[9],"into":[10],"question":[11],"due":[12],"to":[13,28,105,121,168,258],"the":[14,30,107,122,202,254],"contradictory":[15],"information":[16],"available":[17],"about":[18],"it.":[19],"A":[20],"meta-analysis":[21,52,70],"risk":[23,280],"benefit":[24],"assessment":[25],"was":[26,57,71,163,206],"conducted":[27,58,104],"address":[29],"various":[31],"points":[32],"debate":[34],"regarding":[35],"Pio.":[36],"Electronic":[37],"database":[38],"search":[39],"(Cochrane":[40],"library,":[41],"Embase":[42],"&":[43],"PubMed)":[44],"resulted":[45,130],"in":[46,87,131,138,161,166,212,216,287],"10":[47],"citations":[48],"eligible":[49],"for":[50,191,273],"this":[51],"(prospective,":[53],"randomised":[54],"studies),":[55],"which":[56],"using":[59],"CMA":[60],"software":[61],"version":[62],"3":[63],"(Biostat":[64],"Inc.,":[65],"Englewood,":[66],"NJ,":[67],"USA).":[68],"registered":[72],"with":[73,80,89,208,277],"PROSPERO":[74],"(ID:":[75],"CRD42019122403)":[76],"compared":[78,120],"a":[81,132,209],"control":[82,123],"(anti-hyperglycemic":[83],"agents":[84],"without":[85],"pioglitazone)":[86],"patients":[88,289],"either":[90],"established":[91,282],"cardiovascular":[92,97,283],"disease":[93,285],"or":[94,281],"having":[95],"high":[96,278],"risk.":[98],"Sensitivity":[99],"subgroup":[101,171],"analysis":[102],"were":[103],"differentiate":[106],"effect":[108,234],"Pio":[110,119,129,174,205,230,241,268],"against":[111],"active":[112],"controls":[113],"placebo.":[115],"use":[117,128,203],"group":[124],"that":[125],"did":[126],"not":[127,164,296],"14%":[133],"23%":[135],"significant":[136,165,210,233],"reduction":[137,160],"odds":[139,177,213],"major":[141],"adverse":[142],"cardiac":[143],"events":[144],"(MACE:":[145],"MH-OR,":[146],"0.86;":[147],"95%":[148,155,184,197,220,227],"CI":[149,156,185,198,221,228],"0.75-0.98),":[150],"stroke":[152,162],"(MH-OR,":[153,182,195,218,225],"0.77;":[154],"0.60-0.99),":[157],"respectively.":[158],"This":[159],"comparison":[167],"placebo":[169],"on":[170,235,245],"analysis.":[172],"However,":[173],"significantly":[175],"increased":[176],"heart":[179,192,263],"failure":[180,193],"(HF)":[181],"1.47;":[183],"1.26-1.71)":[186],"as":[187,189],"well":[188],"hospitalization":[190],"(hHF)":[194],"1.48;":[196],"1.21-1.81).":[199],"In":[200],"addition,":[201],"associated":[207],"increase":[211],"fractures":[215],"women":[217],"2.05;":[219],"1.28-3.27)":[222],"anaemia":[224],"2.56;":[226],"1.55-4.21).":[229],"has":[231,242],"no":[232],"bladder":[236],"cancer":[237],"nor":[238],"macular":[239],"oedema.":[240],"salutary":[243],"effects":[244,249],"MACE.":[246],"positive":[248],"are":[250,293],"completely":[251],"offset":[252],"by":[253,260],"harm":[255],"they":[256],"seem":[257],"cause":[259],"way":[261],"failure,":[264],"fractures,":[265],"anaemia.":[267],"should":[269],"therefore":[270],"be":[271],"reserved":[272],"treatment":[274],"T2D":[276],"CV":[279],"(CV)":[284],"only":[286],"selected":[288],"where":[290],"other":[291],"antidiabetics":[292],"precluded":[294],"routinely.":[297]},"counts_by_year":[{"year":2026,"cited_by_count":12},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":7},{"year":2022,"cited_by_count":8},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":1}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2020-10-01T00:00:00"}